Nitazoxanide    (DrugBank: Nitazoxanide)

2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病1
97潰瘍性大腸炎1

96. クローン病 [臨床試験数:2,209,薬物数:1,276(DrugBank:240),標的遺伝子数:166,標的パスウェイ数:210
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00130390
(ClinicalTrials.gov)
August 200512/8/2005Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's DiseaseMulti-center, Randomized, Double-Blind, Placebo-Controlled Trial of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease in AdultsCrohn's DiseaseDrug: Nitazoxanide;Other: PlaceboRomark Laboratories L.C.NULLTerminated18 YearsN/ABoth98Phase 2United States

97. 潰瘍性大腸炎 [臨床試験数:2,269,薬物数:1,331(DrugBank:241),標的遺伝子数:114,標的パスウェイ数:181
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03441893
(ClinicalTrials.gov)
January 1, 20158/2/2018Role of Intestinal Protozoa and Helminths in the Course of Ulcerative ColitisRole of Intestinal Protozoa and Helminths in the Course of Ulcerative ColitisUlcerative Colitis;Ulcerative Colitis Exacerbation;Protozoan Infections;Helminth InfectionDiagnostic Test: parasitological diagnostics (coproscopy);Drug: Nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250MgResearch Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanNULLActive, not recruiting18 Years90 YearsAll300Phase 1;Phase 2NULL